Literature DB >> 15689586

Systemic therapy for colorectal cancer.

Jeffrey A Meyerhardt1, Robert J Mayer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689586     DOI: 10.1056/NEJMra040958

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  369 in total

1.  [ADAM17 knockdown increases sensitivity of SW480 cells to cetuximad].

Authors:  Ying Chen; Kehong Zheng; Zetao Chen; Haizhan Feng; Wei Fang; Zonghai Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

Review 2.  Colorectal cancer molecular biology moves into clinical practice.

Authors:  Colin C Pritchard; William M Grady
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

3.  Comparative evaluation of three 64Cu-labeled E. coli heat-stable enterotoxin analogues for PET imaging of colorectal cancer.

Authors:  Dijie Liu; Douglas Overbey; Lisa D Watkinson; Charles J Smith; Said Daibes-Figueroa; Timothy J Hoffman; Leonard R Forte; Wynn A Volkert; Michael F Giblin
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

4.  Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

Authors:  Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

5.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

Review 6.  Pharmacogenomics in colorectal cancer: the first step for individualized-therapy.

Authors:  Eva Bandrés; Ruth Zárate; Natalia Ramirez; Ana Abajo; Nerea Bitarte; Jesus Garíia-Foncillas
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

7.  Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models.

Authors:  Todd M Pitts; Mark Morrow; Sara A Kaufman; John J Tentler; S Gail Eckhardt
Journal:  Mol Cancer Ther       Date:  2009-01-27       Impact factor: 6.261

8.  Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis.

Authors:  Ciro Franzese; Antonella Fogliata; Tiziana Comito; Angelo Tozzi; Cristina Iftode; Elena Clerici; Davide Franceschini; Pierina Navarria; Anna Maria Ascolese; Lucia Di Brina; Fiorenza De Rose; Giuseppe R D'Agostino; Luca Cozzi; Marta Scorsetti
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

Review 9.  Guanylyl cyclase C as a biomarker in colorectal cancer.

Authors:  Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

10.  High glucose modulates antiproliferative effect and cytotoxicity of 5-fluorouracil in human colon cancer cells.

Authors:  Yi-Shing Ma; I-Ping Yang; Hsiang-Lin Tsai; Ching-Wen Huang; Suh-Hang Hank Juo; Jaw-Yuan Wang
Journal:  DNA Cell Biol       Date:  2013-11-27       Impact factor: 3.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.